Instil Bio TIL
NASDAQ TIL
$6.31 -0.04 (-0.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Instil Bio (TIL) Other Operating Expenses (2024 - 2026)

Updated

Instil Bio's Other Operating Expenses was $1.62 million in Q1 2026.

Analysis

Instil Bio (TIL) Other Operating Expenses (2024 - 2026) Analysis & Trends

For FY2025, Other Operating Expenses at Instil Bio came in at $10 million, unchanged from FY2024.

  • In earlier years, Other Operating Expenses was $10 million in FY2024.
  • The Q1 2026 figure marks the highest quarterly Other Operating Expenses since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Instil Bio 43.07 Mn -256.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.62 Mn
Sep 30, 2024 10.00 Mn
API Access

Instil Bio Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TIL&period=max&api_key=YOUR_API_KEY